Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00482_DB06684_nanopub.RAB1zOpDCxcKez-ct6ZBAn8c68c1atguFVYbx5hI09V-s#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00482_DB06684 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00482_DB06684 label "DDI between Celecoxib and Vilazodone - Selective Serotonin Reuptake Inhibitors may enhance the antiplatelet effect of NSAID (COX-2 Inhibitor). To minimize the risk of bleeding associated with this combination, consider using alternative analgesics, when appropriate, and/or addition of an gastroprotective agent, such as a proton pump inhibitor for the time that combined selective serotonin reuptake inhibitor (SSRIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) is necessary. [drugbank_resource:DB00482_DB06684]" assertion.
- drugbank_resource:DB00482_DB06684 identifier "drugbank_resource:DB00482_DB06684" assertion.
- drugbank_resource:DB00482_DB06684 title "DDI between Celecoxib and Vilazodone - Selective Serotonin Reuptake Inhibitors may enhance the antiplatelet effect of NSAID (COX-2 Inhibitor). To minimize the risk of bleeding associated with this combination, consider using alternative analgesics, when appropriate, and/or addition of an gastroprotective agent, such as a proton pump inhibitor for the time that combined selective serotonin reuptake inhibitor (SSRIs) and nonsteroidal anti-inflammatory drugs (NSAIDs) is necessary." assertion.
- drugbank:DB06684 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00482_DB06684 assertion.
- drugbank:DB00482 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00482_DB06684 assertion.